HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Beverly A Teicher Selected Research

7-aminoactinomycin D

1/2021SMAC Mimetic/IAP Inhibitor Birinapant Enhances Radiosensitivity of Glioblastoma Multiforme.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Beverly A Teicher Research Topics

Disease

82Neoplasms (Cancer)
01/2022 - 01/2002
11Sarcoma (Soft Tissue Sarcoma)
11/2021 - 11/2008
10Carcinoma (Carcinomatosis)
01/2021 - 08/2002
9Small Cell Lung Carcinoma (Small Cell Lung Cancer)
10/2020 - 01/2002
9Neoplasm Metastasis (Metastasis)
08/2014 - 11/2004
8Breast Neoplasms (Breast Cancer)
07/2013 - 08/2002
7Neuroblastoma
01/2020 - 02/2006
6Renal Cell Carcinoma (Grawitz Tumor)
07/2013 - 10/2002
5Multiple Myeloma
07/2015 - 05/2009
4Leukemia
01/2021 - 05/2009
4Osteosarcoma (Osteogenic Sarcoma)
01/2020 - 11/2008
4Ewing Sarcoma (Sarcoma, Ewing)
01/2019 - 03/2011
4Colonic Neoplasms (Colon Cancer)
10/2012 - 02/2006
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2012 - 04/2003
4Ovarian Neoplasms (Ovarian Cancer)
09/2012 - 08/2002
3Adenocarcinoma
12/2021 - 08/2011
3Glioblastoma (Glioblastoma Multiforme)
01/2021 - 01/2009
3Prostatic Neoplasms (Prostate Cancer)
10/2012 - 01/2007
3Melanoma (Melanoma, Malignant)
10/2011 - 04/2008
2Thyroid Neoplasms (Thyroid Cancer)
10/2012 - 09/2012
2Glioma (Gliomas)
10/2012 - 08/2004
2Hypoxia (Hypoxemia)
09/2012 - 01/2005
2Lymphoma (Lymphomas)
10/2009 - 05/2009
1Bites and Stings (Sting)
01/2020
1Wilms Tumor (Wilm's Tumor)
01/2020
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2019
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2019
1Alveolar Rhabdomyosarcoma
01/2019
1Rhabdoid Tumor (Rhabdoid Tumors)
01/2019
1Rhabdomyosarcoma
01/2019

Drug/Important Bio-Agent (IBA)

15Pharmaceutical PreparationsIBA
12/2021 - 09/2003
13Proteins (Proteins, Gene)FDA Link
01/2022 - 08/2004
8Messenger RNA (mRNA)IBA
01/2022 - 03/2004
8Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2012 - 01/2002
7Cytotoxins (Cytolysins)IBA
01/2022 - 03/2008
7Transforming Growth Factor beta (TGF-beta)IBA
07/2008 - 10/2002
6Immunoconjugates (Immunoconjugate)IBA
01/2022 - 09/2012
6Antineoplastic Agents (Antineoplastics)IBA
12/2021 - 08/2002
6Membrane Proteins (Integral Membrane Proteins)IBA
11/2021 - 11/2004
4Transcription Factors (Transcription Factor)IBA
11/2021 - 11/2004
4Biomarkers (Surrogate Marker)IBA
10/2019 - 04/2003
4Topotecan (Hycamtin)FDA LinkGeneric
10/2019 - 10/2008
4Carboplatin (JM8)FDA LinkGeneric
08/2017 - 01/2002
4Adenosine Triphosphate (ATP)IBA
01/2014 - 08/2011
4Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
02/2012 - 01/2002
4Paclitaxel (Taxol)FDA LinkGeneric
10/2009 - 01/2002
3DNA (Deoxyribonucleic Acid)IBA
01/2020 - 01/2011
3Irinotecan (Camptosar)FDA LinkGeneric
01/2020 - 10/2008
3MicroRNAs (MicroRNA)IBA
10/2016 - 07/2012
3Immunoglobulin FragmentsIBA
01/2015 - 10/2011
3AntibodiesIBA
09/2012 - 05/2006
3Genz-644282IBA
02/2012 - 05/2011
3Angiogenesis InhibitorsIBA
11/2011 - 02/2005
3erucylphosphocholineIBA
08/2008 - 09/2003
3CytokinesIBA
08/2006 - 10/2002
2RNA (Ribonucleic Acid)IBA
01/2022 - 02/2007
2AntigensIBA
11/2021 - 04/2008
2Temozolomide (Temodar)FDA LinkGeneric
10/2021 - 01/2017
2GemcitabineFDA Link
10/2019 - 10/2002
2Poly(ADP-ribose) Polymerase InhibitorsIBA
10/2018 - 01/2017
2Monoclonal AntibodiesIBA
01/2016 - 03/2009
2G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2016 - 08/2004
2Bortezomib (Velcade)FDA Link
07/2015 - 03/2015
2Proteasome InhibitorsIBA
07/2015 - 03/2015
2Biological ProductsIBA
11/2014 - 01/2010
2EnzymesIBA
09/2013 - 10/2012
2TubulinIBA
09/2012 - 10/2009
2CamptothecinIBA
05/2011 - 10/2008
2topovaleIBA
05/2011 - 10/2008
2Docetaxel (Taxotere)FDA Link
05/2011 - 10/2009
2Topoisomerase I InhibitorsIBA
05/2011 - 10/2008
2Small Interfering RNA (siRNA)IBA
03/2011 - 01/2010
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
03/2011 - 01/2009
2Transforming Growth Factor beta1 (TGF beta 1)IBA
07/2008 - 11/2003
2matrigelIBA
10/2003 - 09/2003
2CollagenIBA
10/2003 - 09/2003
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2003 - 10/2002
2Protein Kinases (Protein Kinase)IBA
10/2002 - 08/2002
2317615 x 2HClIBA
08/2002 - 01/2002
1trastuzumab deruxtecanIBA
01/2022
1SuspensionsIBA
12/2021
1Lysine (L-Lysine)FDA Link
11/2021
1Histones (Histone)IBA
11/2021
17-aminoactinomycin DIBA
01/2021
1birinapantIBA
01/2021
1Immune Checkpoint ProteinsIBA
01/2021
1CytidineIBA
01/2021
1adavosertibIBA
01/2020
1Aurora KinasesIBA
01/2020
1exodeoxyribonuclease IIBA
01/2020
1VTP50469IBA
12/2019
1ChromatinIBA
12/2019
1Doxorubicin (Adriamycin)FDA LinkGeneric
10/2019
1Cisplatin (Platino)FDA LinkGeneric
10/2019
1ProdrugsIBA
01/2019
1prexasertibIBA
01/2019

Therapy/Procedure

33Therapeutics
01/2022 - 01/2002
7Drug Therapy (Chemotherapy)
01/2021 - 10/2002
3Radiotherapy
10/2018 - 08/2002
1Precision Medicine
12/2021